Oramed Pharmaceuticals annual ebitda
2012
2013
2014
Oramed Pharmaceuticals EBITDA Growth & History (ORMP)
Oramed Pharmaceuticals's calculated EBITDA was −$5.9M for fiscal 2014.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2014 | 2014-08-31 | −$5.9M | −$10.2M | — |
| 2013 | 2013-08-31 | $4.3M | $7.2M | — |
| 2012 | 2012-08-31 | −$2.9M | — | — |
Oramed Pharmaceuticals quarterly ebitda
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2016 | 2016-05-31 | $2.1M | $3.8M | — |
| Q2 2016 | 2016-02-29 | −$1.9M | −$10,000 | — |
| Q1 2016 | 2015-11-30 | $2.5M | $7.9M | — |
| Q3 2015 | 2015-05-31 | −$1.6M | −$3.5M | — |
| Q2 2015 | 2015-02-28 | −$1.7M | −$487,000 | — |
| Q1 2015 | 2014-11-30 | −$1.9M | −$735,000 | — |
| Q4 2014 | 2014-08-31 | −$5.5M | — | — |
| Q3 2014 | 2014-05-31 | $1.9M | — | — |
| Q2 2014 | 2014-02-28 | −$1.2M | — | — |
| Q1 2014 | 2013-11-30 | −$1.2M | — | — |
Oramed Pharmaceuticals ebitda trends
Across the available reported history, Oramed Pharmaceuticals's ebitda decreased from $4.3M to −$5.9M, a change of −$10.2M. The latest reported quarter, Q3 2016, shows $2.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals filings at SEC.gov ↗